In this vein, O’Donnell (O’Donnell et al., 2021) and others (Rowland et al., 2019) have pursued SMAhRTs, Select Modulators of AhR-regulated Transcription, to specifically exploit the anti-cancer functions of AhR. The gene discussed is AHR; the disease is cancer.